In a patient with a large asymmetrically enlarged right thyroid lobe showing multinodular goiter with substernal/mediastinal extension, mild leftward tracheal shift, an aberrant retro‑esophageal right subclavian artery, and no significant airway narrowing or pathologic lymphadenopathy, what are the appropriate next diagnostic and management steps?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Next Steps for Multinodular Goiter with Substernal Extension and Aberrant Anatomy

Given the substernal extension, mass effect, and aberrant retro-esophageal right subclavian artery (which signals high risk for nonrecurrent laryngeal nerve), this patient requires thyroid function testing, ultrasound-guided fine-needle aspiration of suspicious nodules, and surgical referral to a high-volume thyroid surgeon for definitive management. 1, 2

Immediate Diagnostic Workup

Thyroid Function Assessment

  • Measure serum TSH first to determine if the goiter is toxic (hyperfunctioning) or nontoxic, as this fundamentally changes management strategy 2, 3
  • If TSH is suppressed, measure free T4 and total T3 to confirm thyrotoxicosis and consider radioiodine uptake scan to differentiate toxic multinodular goiter from other causes 3
  • Euthyroid patients proceed directly to nodule evaluation 4

Nodule Risk Stratification and Biopsy

  • Perform high-resolution thyroid ultrasound to characterize individual nodules for malignancy risk using ACR TI-RADS or similar criteria 5, 6
  • Obtain ultrasound-guided fine-needle aspiration of any nodules meeting size and sonographic criteria for biopsy, as approximately 5% of multinodular goiters harbor malignancy 6, 4
  • The presence of multiple nodules does not reduce cancer risk; each suspicious nodule requires individual assessment 6, 4

Critical Anatomic Consideration

Aberrant Vascular Anatomy and Surgical Risk

  • The retro-esophageal right subclavian artery identified on imaging strongly predicts the presence of a nonrecurrent right laryngeal nerve (occurs in <1% of cases), which takes an aberrant course directly from the cervical vagus and is at significantly higher risk for injury during thyroidectomy 1
  • This anatomic variant mandates preoperative notification to the surgeon and consideration for preoperative laryngoscopy to document baseline vocal fold function 1
  • Referral to a high-volume thyroid surgeon (>100 thyroidectomies annually) is essential, as complication rates are 4-fold higher with low-volume surgeons 2

Indications for Surgery

This Patient Meets Multiple Surgical Criteria

  • Substernal/mediastinal extension is an indication for surgery because radioactive iodine is less effective for substernal goiters and surgery provides definitive decompression 2, 7, 8
  • Mass effect with tracheal deviation, even without significant luminal narrowing currently, warrants surgical intervention before progressive growth causes airway compromise 7, 8, 9
  • Large asymmetric goiters should be treated surgically before they develop further substernal extension, as sudden growth can seriously compromise respiration 7

Observation is Not Appropriate

  • While asymptomatic nontoxic multinodular goiters with benign cytology may be observed in some cases 10, 4, this patient's substernal extension and mass effect preclude conservative management 2, 7
  • Levothyroxine suppression therapy is controversial and ineffective for reducing established multinodular goiter size 10

Preoperative Planning

Additional Imaging Already Complete

  • The CT scan already performed has appropriately documented substernal extension and tracheal displacement 5
  • CT is superior to ultrasound and MRI for evaluating substernal extension and degree of tracheal compression 5
  • No additional cross-sectional imaging is needed unless malignancy is confirmed on FNA 5

Preoperative Laryngoscopy

  • Obtain baseline laryngoscopy to document vocal fold mobility before surgery, as detection of vocal fold paralysis doubles when routine preoperative examination is performed 1
  • This is particularly important given the aberrant vascular anatomy predicting nonrecurrent laryngeal nerve 1

Common Pitfalls to Avoid

  • Do not delay surgery for levothyroxine suppression trials in patients with substernal goiters, as medical therapy is ineffective and delays definitive treatment 2, 10
  • Do not assume all nodules are benign simply because multiple nodules are present; FNA of suspicious nodules is mandatory 6, 4
  • Do not proceed to surgery without informing the surgeon about the retro-esophageal subclavian artery, as this predicts nonrecurrent laryngeal nerve anatomy 1
  • Do not use radioactive iodine as first-line therapy for substernal goiters, as it is less effective than surgery for this indication 2

References

Guideline

clinical practice guideline: improving voice outcomes after thyroid surgery.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2013

Guideline

Thyroid Disorders: Graves' Disease and Multinodular Goiter

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic and Initial Management of Thyrotoxic Goiter

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Approach to the patient with nontoxic multinodular goiter.

The Journal of clinical endocrinology and metabolism, 2011

Guideline

acr appropriateness criteria<sup>®</sup> thyroid disease.

Journal of the American College of Radiology, 2019

Guideline

Differential Diagnoses for Nontoxic Goiter

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Giant Intrathoracic Goiter of Atypical Presentation: A Case Report.

Clinical pathology (Thousand Oaks, Ventura County, Calif.), 2020

Research

A retropharyngeal multinodular goiter: A case report and literature review.

International journal of surgery case reports, 2022

Research

Evaluation and management of multinodular goiter.

Otolaryngologic clinics of North America, 1996

Related Questions

What is the next step in managing a patient with a multinodular thyroid goiter and bilateral lesions?
In a 76‑year‑old female with a non‑toxic multinodular goitre on carbimazole 5 mg twice daily, suppressed thyroid‑stimulating hormone, low‑normal triiodothyronine, elevated thyroxine, and HbA1c 6.01 % undergoing pre‑operative assessment for orthopedic hip surgery, what endocrine review and peri‑operative management should be documented?
According to the American Thyroid Association guidelines, what postoperative management and surveillance are recommended for a patient with multiple non‑toxic goiters who has undergone total thyroidectomy?
What is the management approach for a patient with a benign colloid nodule and toxic multinodular (c) goitre?
How should brittle hypothyroidism be managed in a patient with multinodular goitre?
What is the interpretation and recommended management of a urinalysis showing cloudy yellow urine with trace leukocyte esterase, greater than 30 white blood cells per high‑power field, 1+ occult blood with 3‑10 red blood cells per high‑power field, 4+ protein, 1+ glucose, hyaline casts, and more than 10 non‑renal epithelial cells?
How do lamotrigine and lurasidone compare in terms of indications, dosing, efficacy, and side‑effect profiles for treating bipolar disorder?
In an otherwise healthy adult who regularly performs strength training and cardiovascular exercise, which beta‑blocker—nebivolol 5 mg, bisoprolol 5 mg, or metoprolol 200 mg—is most appropriate to increase heart‑rate variability while preserving exercise performance?
What is the appropriate treatment for erythematous, scaly skin on the bridge of the nose?
Can acalabrutinib lower the white blood cell count (WBC)?
What can be given to an adult post‑bronchoscopy for bronchiectasis with irritating non‑productive cough?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.